Healthcare | August 09, 2021
India's doctor-population ratio to reach WHO benchmark soon: Dr Vinod Paul
By 2022, 150,000 primary health care centres would be in place in rural as well as urban areas
By 2022, 150,000 primary health care centres would be in place in rural as well as urban areas
It had an estimated market size of US $ 32 million as of June 2021
Lasa Supergenerics Limited has received WHO GMP Certificate for its manufacturing facility situated at Khed in Ratnagiri.
The innovation is particularly suited for bone and cartilage repair
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
Paves the way for next-gen ultra-precise gas sensing
In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga
The results were consistent across both the 10 mg and 40 mg treatment arms
Immediate U.S. launch planned for Farxiga®-equivalent diabetes drug; opportunity pegged at $10.2 billion in annual market size
Immediate opportunity in the $10.2 billion U.S. market as the diabetes therapy will be manufactured at Zydus’ SEZ Ahmedabad facility
Subscribe To Our Newsletter & Stay Updated
